Correspondence 0001104659-23-033229 from ONCOLYZE, INC. (CIK 0001917375)
ONCOLYZE, INC. (CIK 0001917375)
Date: March 16, 2023 · CIK: 0001917375 · Accession: 0001104659-23-033229
AI Filing Summary & Sentiment
File numbers found in text: 024-11890
Letter
Re: Oncolyze, Inc.
Office of Life Sciences
Division of Corporation Finance
Securities and Exchange Commission Washington, DC 20549
March 16, 2023
Post-Qualification Amendment to Offering Statement on Form 1-A
File No. 024-11890
Ladies and Gentlemen:
On behalf of Oncolyze, Inc., I hereby request qualification of the above-referenced offering statement at 2:00 P.M., Eastern Time, on Monday, March 20, 2023, or as soon thereafter as is practicable.
Sincerely,
/s/ Steven J. Evans
Show Raw Text
CORRESP 1 filename1.htm Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission Washington, DC 20549 March 16, 2023 Re: Oncolyze, Inc. Post-Qualification Amendment to Offering Statement on Form 1-A File No. 024-11890 Ladies and Gentlemen: On behalf of Oncolyze, Inc., I hereby request qualification of the above-referenced offering statement at 2:00 P.M., Eastern Time, on Monday, March 20, 2023, or as soon thereafter as is practicable. Sincerely, /s/ Steven J. Evans Steven J. Evans Chief Executive Officer Oncolyze, Inc. Cc: Jeanne Campanelli CrowdCheck Law LLP